Try our beta test site

Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT00568984
First received: December 4, 2007
Last updated: February 17, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 10, 2003
  Primary Completion Date: November 10, 2003 (Final data collection date for primary outcome measure)